Skip to main content
Toggle navigation
Login
Search
Home
Tweets by ASCPT 2023 Annual Meeting
Home
Browse by Poster Presenter
Browse by Poster Presenter
Type here to filter the list
All
A
B
C
D
E
F
G
H
I
J
K
L
M
N
O
P
Q
R
S
T
U
V
W
X
Y
Z
M
Maas, Brian
Merck & Co.
LB-004
-
MOLNUPIRAVIR EXPOSURE-RESPONSE OF CLINICAL OUTCOMES IN TREATMENT OF COVID-19.
Brian Maas
Favorite
Manting, Chiang
Bristol Myers Squibb
PI-058
-
DRUG-DRUG INTERACTION POTENTIAL OF MAVACAMTEN WITH ORAL CONTRACEPTIVES: RESULTS FROM A CLINICAL PHARMACOKINETIC STUDY.
Chiang Manting
Favorite
Martin, James
University of Colorado Anschutz Medical Campus
PI-023
-
CHARACTERISTICS OF PROVIDERS WHO RESPONDED TO PASSIVE CLINICAL DECISION SUPPORT ALERTS FOLLOWING PRE-EMPTIVE RETURN OF PHARMACOGENOMIC RESULTS.
James Martin
Favorite
PII-111
-
EVALUATION OF SEX DIFFERENCES IN MEDICATION PRESCRIBING RECOMMENDATIONS AND OCCURRENCE OF ADVERSE EVENTS.
James Martin
Favorite
PWIII-003
-
CHARACTERISTICS OF PROVIDERS WHO RESPONDED TO PASSIVE CLINICAL DECISION SUPPORT ALERTS FOLLOWING PRE-EMPTIVE RETURN OF PHARMACOGENOMIC RESULTS.
James Martin
Favorite
Mascelli, Mary Ann
Kyowa Kirin Co., Ltd.
PI-038
-
APPLICATION OF MODELING AND SIMULATION TO EXTRAPOLATE THERAPEUTIC BUROSUMAB DOSING REGIMENS FOR SUBJECTS WITH PEDIATRIC TUMOR-INDUCED OSTEOMALCIA.
Mary Ann Mascelli
Favorite
Ma, Xiaotang
Bristol Myers Squibb
PI-102
-
POST MARKETING COMMITMENT OR REQUIREMENT (PMC/R) FOR RECENT APPROVED DRUG PRODUCTS: SUMMARY FROM CLINICAL PHARMACOLOGY (CP) PERSPECTIVES.
Xiaotang Ma
Favorite
Mc Laughlin, Anna
Pharmetheus
PII-041
-
POTENTIAL STRATEGIES TO OPTIMIZE CAR-T CELL EXPOSURE IN ABSENCE OF DOSE-EXPOSURE RELATIONSHIPS LEVERAGING CELL KINETIC/DYNAMIC MODELS.
Anna Mc Laughlin
Favorite
McComb, Mason
Amgen Inc.
PI-101
-
AN OPEN-LABEL SINGLE-DOSE STUDY TO EVALUATE THE PHARMACOKINETICS OF SOTORASIB IN HEALTHY SUBJECTS AND SUBJECTS WITH MODERATE OR SEVERE HEPATIC IMPAIRMENT.
Mason McComb
Favorite
McIntire, Carter
Cincinnati Children's Hospital Medical Center
PII-117
-
PIPERACILLINE PHARMACOKINETICS AND PHARMACODYNAMICS IN PEDIATRIC PATIENTS WHO RECEIVED HIGH FREQUENCY PIPERACILLIN/TAZOBACTAM DOSING DURING SURGERY.
Carter McIntire
Favorite
McNamee, Brian
AbbVie Inc.
PII-087
-
THE EFFECT OF FOOD ON T3 AND T4 BIOAVAILABILITY AND THE DOSE PROPORTIONALITY OF ARMOUR THYROID.
Brian McNamee
Favorite
Mease, James
US Food and Drug Administration
PT-021
-
PHARMACOKINETIC (PK) BASIS OF STATIN DRUG-DRUG INTERACTION (DDI) INFORMATION IN FDA LABELS.
James Mease
Favorite
Mehanna, Mai
University of Florida
EP-002
-
INTEGRATED METABOLOMICS ANALYSIS REVEALS MECHANISTIC INSIGHTS INTO THE ANCESTRAL DIFFERENCES IN PLASMA RENIN ACTIVITY AMONG PATIENTS WITH HYPERTENSION AND THIAZIDE DIURETICS BLOOD PRESSURE LOWERING EFFECTS.
Mai Mehanna
Favorite
Mehta, Jaydeep
Janssen Research and Development LLC
PI-100
-
THE DRUG-DRUG INTERACTION (DDI) EFFECT OF STEADY STATE ITRACONAZOLE EXPOSURE ON SINGLE DOSE PHARMACOKINETICS (PK) OF LAZERTINIB.
Jaydeep Mehta
Favorite
Mehta, Parsshava
University of Florida
PT-023
-
DEVELOPMENT OF INTRANASAL PHYSIOLOGICALLY BASED NOSE TO BRAIN MODEL AND ITS APPLICATION TO CHARACTERIZE IN NEUROEPO ABSORPTION VIA NASAL ROUTE AND DISTRIBUTION TO LUMBAR CSF IN HEALTHY NON-HUMAN PRIMATES (CYANOMOLGUS MONKEY).
Parsshava Mehta
Favorite
Meiman, Darius
Indiana University
PII-099
-
PHYSIOLOGICALLY BASED PHARMACOKINETIC MODEL TO ASSESS THE DRUG-DRUG-GENE INTERACTION POTENTIAL OF BELZUTIFAN IN COMBINATION WITH CYCLIN-DEPENDENT KINASE 4/6 INHIBITORS IN HEALTHY VOLUNTEERS.
Darius Meiman
Favorite
Mendell, Jeanne
Regeneron Pharmaceuticals, Inc.
PII-074
-
PHARMACOKINETICS OF MIBAVADEMAB (MIBA) IN HEALTHY PARTICIPANTS: RESULTS FROM A RANDOMIZED, PHASE 1, TWO-PART, FIRST-IN-HUMAN STUDY.
Jeanne Mendell
Favorite
Miller, Emily
Virginia Commonwealth University
PII-030
-
IMPACT OF COMORBID PAIN, PSYCHIATRIC DIAGNOSES, AND SUBSTANCE USE DISORDERS ON OPIOID USE DISORDER TREATMENT IN PERSONS WITH AND WITHOUT HIV.
Emily Miller
Favorite
RWE-003
-
IMPACT OF COMORBID PAIN, PSYCHIATRIC DIAGNOSES, AND SUBSTANCE USE DISORDERS ON OPIOID USE DISORDER TREATMENT IN PERSONS WITH AND WITHOUT HIV.
Emily Miller
Favorite
Mir, Nabiel
The University of Chicago
PII-127
-
GERIATRIC REMOTE INITIATIVE (GeRI): IMPLEMENTING REMOTE ASSESSMENTS OF TOXICITY AND FRAILTY FOR OLDER ADULTS WITH CANCER.
Nabiel Mir
Favorite
RWE-004
-
GERIATRIC REMOTE INITIATIVE (GeRI): IMPLEMENTING REMOTE ASSESSMENTS OF TOXICITY AND FRAILTY FOR OLDER ADULTS WITH CANCER.
Nabiel Mir
Favorite
Mizuno, Kana
Cincinnati Children's Hospital Medical Center
PI-060
-
ECULIZUMAB COMPLEMENT-MEDIATED PK/PD MODEL-INFORMED SIMULATIONS REVEAL THE NEED FOR ALTERNATIVE DOSING REGIMENS DURING MAINTENANCE THERAPY FOR STEM CELL TRANSPLANT-ASSOCIATED THROMBOTIC MICROANGIOPATHY (TA-TMA).
Kana Mizuno
Favorite
Molla, Hanna
The University of Chicago
PII-033
-
THE EFFECTS OF AN ACUTE ORAL DOSE OF METHAMPHETAMINE ON NEURAL ACTIVATION DURING PERFORMANCE ON A MONETARY REWARD TASK IN HEALTHY ADULTS.
Hanna Molla
Favorite
Morcos, Peter
Bayer
PII-075
-
PHARMACOMETRICS (PMX) APPROACH TO SUPPORT PEDIATRIC DOSING FOR THE PAN-PI3K INHIBITOR COPANLISIB IN CHILDREN AND ADOLESCENTS WITH RELAPSED/REFRACTORY SOLID TUMORS.
Peter Morcos
Favorite
Movafagh, Shahrzad
Sheanndoah University
EP-010
-
HYPOXIA INDUCIBLE FACTOR-1A POLYMORPHISMS ASSOCIATED WITH ADVANCED CHRONIC KIDNEY DISEASE.
Shahrzad Movafagh
Favorite
Mukker, Jatinder
EMD Serono
PI-071
-
HOLISTIC INTEGRATION OF POPULATION PHARMACOKINETICS, PHARMACODYNAMICS AND SAFETY TO DEFINE RECOMMENDED DOSE FOR EXPANSION OF ATR INHIBITOR, M1774: AN ILLUSTRATION OF MODEL-INFORMED EARLY ONCOLOGY DRUG DEVELOPMENT.
Jatinder Mukker
Favorite
Murphy, William
University of North Carolina at Chapel Hill
PII-027
-
LEVERAGING MACHINE LEARNING (ML) TO QUANTIFY CHANGES IN CELLULAR LOCALIZATION AND ZONAL DISTRIBUTION OF TRANSPORTERS IN LIVER TISSUE FROM PATIENTS WITH NONALCOHOLIC FATTY LIVER DISEASE (NAFLD).
William Murphy
Favorite
